MAPK3 and Alzheimer disease: The AD-like effects of catalpol might be due to HO-1 that up-regulates the ERK1/2/Nrf2/HO-1 pathway-related factors to enhance the antioxidant defence, triggering the down-regulation of the COX-2/iNOS/NO pathway-related factors to inhibit NI, and the up-regulation of the BDNF/TrkB pathway to enhance neurotrophic effects